All five markers of obesity-related inflammation in the hippocampus (Il-6, Tnf-α, Cd11c, Tlr4 and Nptx251,52) were down-regulated by ENOblock treatment (Fig. 6A). This evidence concerns the gene IL6 and obesity disorder.